Page last updated: 2024-09-02

tamibarotene and Sclerosis, Systemic

tamibarotene has been researched along with Sclerosis, Systemic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akamata, K; Asano, Y; Ichimura, Y; Kadono, T; Noda, S; Sato, S; Shudo, K; Takahashi, T; Taniguchi, T; Toyama, T1

Other Studies

1 other study(ies) available for tamibarotene and Sclerosis, Systemic

ArticleYear
Tamibarotene Ameliorates Bleomycin-Induced Dermal Fibrosis by Modulating Phenotypes of Fibroblasts, Endothelial Cells, and Immune Cells.
    The Journal of investigative dermatology, 2016, Volume: 136, Issue:2

    Topics: Animals; Benzoates; Bleomycin; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Female; Fibroblasts; Fibrosis; Flow Cytometry; Humans; Immunohistochemistry; Interleukins; Macrophages; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Transgenic; Phenotype; Protein Serine-Threonine Kinases; Random Allocation; Real-Time Polymerase Chain Reaction; Scleroderma, Systemic; Sensitivity and Specificity; Tetrahydronaphthalenes; Tumor Necrosis Factor-alpha

2016